POLIOVAX-IN İtalya - İtalyanca - AIFA (Agenzia Italiana del Farmaco)

poliovax-in

glaxosmithkline vaccines s.r.l. - vaccino poliomielitico, trivalente, inattivato, virus intero - vaccino poliomielitico, trivalente, inattivato, virus intero

Nuvaxovid Avrupa Birliği - İtalyanca - EMA (European Medicines Agency)

nuvaxovid

novavax cz, a.s. - sars cov-2 (original) recombinant spike protein, sars-cov-2 (omicron xbb.1.5) recombinant spike protein - covid-19 virus infection - covid-19 vaccines - nuvaxovid is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. l'uso di questo vaccino dovrebbe essere in conformità con le raccomandazioni ufficiali. nuvaxovid xbb. 5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. l'uso di questo vaccino dovrebbe essere in conformità con le raccomandazioni ufficiali.

Bimervax Avrupa Birliği - İtalyanca - EMA (European Medicines Agency)

bimervax

hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vaccini - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.

ANATOSSINA STAFILOCOCCICA İtalya - İtalyanca - AIFA (Agenzia Italiana del Farmaco)

anatossina stafilococcica

glaxosmithkline vaccines s.r.l. - altri vaccini batterici - altri vaccini batterici

INFLUPOZZI ZONALE İtalya - İtalyanca - AIFA (Agenzia Italiana del Farmaco)

influpozzi zonale

glaxosmithkline vaccines s.r.l. - vaccini influenzali - vaccini influenzali

FLUVIRIN İtalya - İtalyanca - AIFA (Agenzia Italiana del Farmaco)

fluvirin

evans vaccines limited - vaccini influenzali - vaccini influenzali

Celvapan Avrupa Birliği - İtalyanca - EMA (European Medicines Agency)

celvapan

nanotherapeutics bohumil, s.r.o. - whole virion influenza vaccine, inactivated containing antigen of strain a/california/07/2009 (h1n1)v - disease outbreaks; influenza, human; immunization - vaccini - profilassi dell'influenza causata dal virus a (h1n1) v 2009. celvapan dovrebbe essere usato in conformità con le linee guida ufficiali.

Infanrix Penta Avrupa Birliği - İtalyanca - EMA (European Medicines Agency)

infanrix penta

glaxosmithkline biologicals s.a. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), poliovirus (inactivated) (type 1 (mahoney strain), type 2 (mef-1 strain), type 3 (saukett strain)), hepatitis b surface antigen - hepatitis b; tetanus; immunization; whooping cough; poliomyelitis; diphtheria - vaccini - infanrix penta è indicato per la vaccinazione primaria e di richiamo di neonati contro difterite, tetano, pertosse, epatite b e poliomielite.

Coxevac Avrupa Birliği - İtalyanca - EMA (European Medicines Agency)

coxevac

ceva santé animale - vaccino coxiella burnetii inattivato, ceppo nove mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.

BCG Vaccine SSI Sostanza secca con Solvens İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

bcg vaccine ssi sostanza secca con solvens

pro farma ag - mycobacterium bovis (stamm: danese ceppo 1331) - sostanza secca con solvens - preparazione cryodesiccata: mycobacterium mucca (stamm: danese ceppo 1331) 2-8 x 10e6 cfu, natrii hydrogenoglutamas anhydricus, per il vetro. il rilascio di: magnesio sulfas heptahydricus, kalii hydrogenophosphas, acido citricum monohydricum, asparaginum monohydricum, ammonii portato citras, glycerolum (85 per cento), acqua q.s. per una soluzione invece di 1 ml. - prevenzione della tubercolosi disseminata prima 1. compleanno - vaccini